Local and International Biopharma Community Convenes at Korea’s Largest Biomanufacturing, CGT and Biologistics Co-located Event
|Update : 28th April, 2022
As COVID-19 related restrictions ease up in Korea, the region’s many Biopharmaceutical manufacturing and logistics leadership personnel will gather in-person for the biggest Biomanufacturing, CGT and Biologistics co-located conferences on the calendar, the 11th Annual Biologics Manufacturing Korea, Cell and Gene Therapy World East Asia and 3rd Annual Biologistics World Korea, held at Songdo Convention Center on 29th – 30th June.
C-level and Vice President level leadership of companies such as PharmAbcine, Orgenesis, Rznomics, Celltrion and more will speak at the BioManufacturing World Korea conference, where they will join an agenda built around success stories from Korean biopharmas. There will be presentations on the latest manufacturing technologies, as well as an exhibition of the leading solutions available to bioprocessing businesses.
Logistics and cold chain management from biopharma manufacturers such as Santen, SUN Pharma, Johnson & Johnson and more will join the supply chain heads of major companies like Cold Chain Platform, Hanmi Pharmaceuticals, Blue Blood Biotech, British Standards Institute, Singapore Health Promotion Board and more. Crucial issues in cold chain management, end-to-end logistics excellence and packaging will be discussed alongside an exhibition for leading logistics vendors.
With significant opportunities abounding in biologics manufacturing and vaccine development, technologies like single-use and continuous processing for biologics, key challenges in cell therapy manufacture, cost-reduction in downstream processing as well as pathogen safety will be crucial points of interest and all are unpacked by those most qualified to talk about them at this event.
At the same time the actual delivery of highly time and temperature sensitive products to those that need them the most is beset by major challenges in the form of cold chain maintenance, freight forecasting and the need to digitalise further, making biologistics crucially important. These issues will be discussed at the BioLogistics event exclusively by those with the experience to do justice to the topics.
Alongside the conferences, the Korea Bioprocessing Excellence Awards will be taking place. This awards show seeks to give recognition to exceptional bioprocessing experts, organizations and technologies that facilitate biomanufacturing and biologistics excellence at enhanced speed, reduced cost, and superior quality. Featuring top bioprocessing, biomanufacturing and supply chain leaders in the industry, along with the latest advances in technologies and best practices in manufacturing, the Korea Bioprocessing Excellence Awards applauds extraordinary leaders & trend-setters of today and inspires innovators of tomorrow.
The organiser, IMAPAC, is a home-grown Singaporean firm that acts as a biopharma marketing partner to the industry and uplifts the research and commercial arms of biopharma in Asia. IMAPAC is welcoming media from Korea to join the event, meet the region’s biopharma leadership and take pictures as well as cover the event for their respective publications.
Coverage of the event will provide access to 400 in-person attendees, mixed networking between all co-located events, 20+ networking hours, 40+ case studies across all events, comprising around 1000 professionals from within the industry.
Registration Link: https://imapac.com/biologistics-world-korea/#ticket-on-sale-now-1
IMAPAC Pte Ltd started in Singapore in 2010 with providing quality conference and networking opportunities for businesses in the life science industry. As it has expanded its portfolio by venturing into market research reports, webcasts, and digital solutions, it has now become the one-stop solution for business intelligence and networking activities in the life science industry. Over the past 3 to 5 years IMAPAC has launched multiple new projects and even moved into newer geographies. In 2017 IMAPAC launched the Logistics portfolio with conferences in Singapore and Korea, which now we are expanding into Japan. In 2018 IMAPAC launched the first event in Northern Europe with a very successful launch of the Biologics World Nordics catering to the Scandinavian market. IMAPAC has also moved the Biologics Manufacturing Asia from China to Singapore and it is now the flagship show for the Industry in Singapore with over 40 exhibitors and 500 attendees. Lastly continuing on our geographic expansion in 2019 IMAPAC has moved into the Japan market with the launch of the Biologics Manufacturing Japan.
We have also launched our market research division in 2019 where we are producing bespoke market Intelligence reports on the different segments in the Life Science industry. Additionally we have launched our LeadGen 360 digital solutions in aiding the biopharma and life science companies to create brand awareness, generate high quality leads and do top-notch product launches.
Source : IMAPAC